Namma Bengaluru gets ready for the 11 th Edition of Bengaluru INDIA NANO 2020

2nd- 4th March, 2020 | Venue: Hotel the Lalit Ashok, Bengaluru

Bengaluru 17th  January 2020: The 11th  edition of Bengaluru India Nano, one of the front running events of the Department of IT, BT and S&T, Government of Karnataka will be held on 2 nd  and 3 rd  March 2020 with tutorials on 4 th March at The Lalit Ashok, Bengaluru. This year’s theme is ‘New Dimensions in Nanoscience and Nanotechnology for Industry 4.0’. The event is being held in association with Karnataka’s Vision Group on Nanotechnology, chaired by Prof. C.N.R. Rao, FRS, National Research Professor; Linu Pauling Research Professor & Honorary President, Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR). Bengaluru India Nano offers an unparalleled opportunity for business networking and for knowledge sharing in the exciting field of Nanotechnology and it has now evolved as the leading and most sought-after international Nanotech event in India.

Delivering the keynote address, Dr. C N Ashwath Narayan, Deputy Chief Minister, Minister for IT, BT and S&T and Minister for higher education and medical education, Government of Karnataka, said, “The focal theme of the 11th Bengaluru India Nano – ‘New Dimensions in Nanoscience and Nanotechnology for Industry 4.0’; has been aptly chosen by the Vision Group on Nanotechnology led by Bharat Ratna Prof. C N R Rao. Bengaluru India Nano has always been receiving tremendous response from Research,Academia and Industry and is today on the radar of many countries for connecting with who’s who of the Indian Nanotech fraternity. I foresee that nanotechnology will provide a window of opportunity to apply technology applications in medicine, health care, energy, electronics, information technology, biotechnology, and so on, besides forging economic growth of the nation. Our Government will extend all possible help and support for the growth of this new sunrise industry in the State.” 

Bengaluru India Nano will discuss a range of issues pertaining to Research, Technology Development, Skills Requirement, Institutions Involved, Risks Issues, Regulatory & Governance Structure, Investment and Collaborations between R&D, Academia & Industry. The event is expected to have significant participation from Chief Scientific Officers, Chief Technology Officers, Policy Makers,  Scientists, Chemists, Research Leaders ,Fellows , Advisors from Industry, Venture capitalists,  Governments and Research Institutions.

Delivering the inaugural address, Dr. E V Ramana Reddy, Additional Chief Secretary, Department of IT, BT and S&T and Department of Urban Development, said, “It is predicted that this emerging technology is expected to become a greater economic force than any other technologies in the years to come. The global market for Nanotechnology is projected to reach $125.70 billion by 2024, driven by growing R&D efforts directed at enabling the development of nanotech-based products and solutions in diverse industries. Nanotechnology will have a broad and fundamental impact on nearly all sectors of the global economy namely electronics, energy, healthcare, consumer goods, defense, automotive, water purification and agriculture among others.

Prof. C N R Rao, FRS, National Research Professor; Linus Pauling Research Professor & Honorary President, Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR)  said, “The Nano Technology space has been growing at a tremendous pace in the recent past. Nanotechnology is today being used across various industries including manufacturing, automotive and healthcare. In fact maximum benefit of nanotechnology has come from Nanomedicine. This presents us with a huge opportunity for research in Nanotechnology in areas such as healthcare and energy. There is also a big opportunity for research in Nanotechnology in the area of pollution in Bengaluru city. I’m sure we can come with some solution using Nanotechnology.”

The 11th edition of Bengaluru INDIA NANO event spectrum includes Multi-Track Conference, International Exhibition, Research Industry Collaboration Hub (RICH), Nan SparX, Nano Excellence Awards, Poster – Walkway of Discovery, B2B partnering and Pre-Conference Tutorials. Over 800 delegates from organizations across the world, over 50 speakers will be participating in the event that includes pre-conference tutorials as well as Plenary and Keynote presentations and brainstorming deliberations along with networking. The International exhibition at Bengaluru INDIA NANO will offer opportunities to various industries to showcase their unique technologies, products and services. It will be an ideal platform for R&D Institutes, corporates, PSUs, Start-ups and educational institutions. DST Nano mission will bring together companies with innovative products and technologies in their pavilion. Other participants in exhibition will include Leading R&D Institutes, Instrumentation Manufacturers & Suppliers, Nano Based Product Companies, DST Nano Mission, Institutions of National Importance, Karnataka Education Pavilion, States of India Start-Ups and Financial Institutions etc.

Nano Excellence Awards for outstanding contribution will be presented in the following categories: Prof. C N Rao Bengaluru India Nano Science Award, Bengaluru INDIA NANO Innovation Award, Malhotra Weikfield Foundation Awards, Nano Science Fellowship Awards, Karnataka DST Nanoscience Fellowships Awards, Nano Sparx, Best Exhibitor and Best Poster Award.

Bengaluru India Nano 2020 will focus largely on Nano in Energy for E-mobility, Nano in Agriculture,  Nano for Clean Water and Environment and  Nano in Manufacturing.

City Today News

(citytoday.media)

9341997936

Equality through ‘Wequity’ for Women and Technology

– A Collaborative to Promote Women in Technology; Wequity Awards Instituted-

Wequity, a social impact company that drives gender equity for the technology ecosystem was launched in Bengaluru today. The company is founded by the voice of women-in-tech stalwart Geetha Kannan, and she is joined by seasoned industry professionals Divya Ravindranath and Abhinaya S Rao as founding team members. Wequity has a core digital offering and supporting in-person services that will deliver the best of networks, knowledge and growth resources to all women seeking to grow in the technology space, and all establishments that intend to enable them. As a first in the country, the company has instituted a set of five unique awards dedicated to women in technology role models, including male sponsors, called the Wequity Awards. Nominations are underway and can be applied at http://wequity.tech/home/apply.

Addressing media persons at the launch of Wequity, Geetha Kannan, Founder and Chief Executive Officer, Wequity said, “We are driven by two principles namely equity and collaboration. Equity means catering to the different needs of people to get to a level place where equality can then apply. We take into consideration the different needs of technical women and technology organizations and provide tailored avenues for them to professionally grow. In order to have an impact, it is imperative that we consistently partner and holistically come together to achieve gender equality. So in everything we do, we operate in a collaborative mode with the women in tech community and their network supporters, which includes technology organizations and eventually academia, entrepreneurs and other ecosystem partners like ourselves.”

Divya Ravindranath, Chief Community Officer and Founding Member, Wequity said, “Our one-of-its-kind, all-encompassing digital platform provides continuous and customized engagement for the women in technology network. ‘Wequity.tech’ will be the first in the world to provide a safe and secure space for any woman to learn, network, explore, teach, mentor and grow through a community driven, self-sustaining model. The platform is only for women, technology organizations and ecosystem collaborators. It is member driven and offers a first level free service with subsequent staged membership options.”

“Wequity is a made in India company that wants to leverage the rich capability and potential we have, our country has some of the best stats in the world for women talent and STEM. Our offerings will focus on gaps in the industry and be curated to address these gaps. Continuous engagement and role models are two areas that drive our current services. Ultimately we want to move the needle far enough in our lifetime so that equality is a status quo for future generations” Geetha added.

Elaborating on the Wequity Awards for Women in Technology, Abhinaya S Rao, Chief Business Officer and Founding Member, Wequity said, “It is essential that we have more visibility of role models in the women-in-tech ecosystem, to inspire possibilities for growth and gender equity. The distinctive Wequity Awards will encourage, recognize and celebrate the achievements of technical women and their key enablers in the industry. These awards will be in two categories namely the ‘technology category and the ‘wequitism category’ Nominations will be open to companies across the country and will be evaluated by a niche panel of industry experts and leaders.

” The five Wequity awards will be the epitome of excellence and inspiration by pushing the bar higher and ensuring role models are made visible. The technical categories include Tech Beacon Award’ for a female technology leader who has influenced through outstanding technology contributions, the Tech Exemplar Award’ for a female technologist who has significant achievements and potential in her area of technical expertise, The Techinist Award’ for a female tech expert who has one or more technical patents through her innovative work. The Wequitism categories include The Equaliser’ for male sponsors (business or tech) whose voice and work has progressed women in technology, and the “Solidarity Idoľ for a female ally (business or tech) who goes out of her way to support women technologists to grow.

While women who join this community will get access to a wide range of resources and connections to boost their prospects, staying power and progress in the tech industry, any establishment which joins this community will get access to deep collaboration and multiple tools to support a more diverse tech workforce through hiring and inclusive actions.

City Today News

(citytoday.media)

9341997936

Ajmal Perfumes partners with Health & Glow to reach out to the mass Indian consumers

January 16th 2020:Shanvi Srivastava the popular South Indian actress unveiled the most popular classical fragrances of Ajmal at Health & Glow today. Ajmal Perfumes, one of the Gulf region’s biggest perfume houses based out of Dubai, with over 300 products in its portfolio.The perfume brand known for its bespoke fragrances is celebrated world-wide for its passion for crafting memories through perfumes ever since its founder Haji Ajmal Ali, created the brand in 1951. As a trader of oudh and oudh oil, Haji Ajmal Ali opened his first store in Mumbai in the 1960s. In 1976, Ajmal opened its doors in the UAE. Currently, Ajmal Perfumes is present in 34 cities with 56 company owned outlets across India. Ajmal is present in all the major online marketplaces too.

Unveiled the most popular classical fragrances of Ajmal The seven-decade old brand is the perfect match for Health & Glow, the beauty destination of India, which has been playing a major role in shaping the idea of beauty and personal care in India for over two decades now.

Commenting on the association, Mr. Abdulla Ajmal, Consultant Perfumer (and third generation of Ajmal) – Ajmal & Sons, India said, “We are ecstatic to partner with Health & Glow, one of the renowned and most trusted beauty retailers in India. This is in line with our brand extension strategy to partner with the best-in-class retail players. With Health & Glow as the partner, we’re confident of stability, sustainability and most importantly, scalability of our brand.”

Commenting on this new format outlet, Mr. Saurav Bhattacharya – President Operations at Ajmal & Sons said, “By leveraging Ajmal’s USP of innovation, and an in- depth knowledge of the clientele that frequents Health & Glow, we are offering customers the very best from Ajmaľ’s world of fragrances, that are now available in select Health & Glow stores & online. We will also keep expanding our footprint in India in the near future to cover the entire gamut of discerning perfume users. We practically started at zero and we aim to get 500 points of sale by the end of March 2020. Post 500 points of sale, we are ambitiously aiming at crossing 2000 points of sale in the next two years.”

Commenting on the collaboration Mr. K Venkataramani, MD & CEO, Health and Glow, said, “We are extremely happy and proud to present Ajmal, one of the greatest perfume brands that is so committed to create the bond between memory and smell. Health & Glow has the legacy of working with reputed brands, and Ajmal Perfumes is no exception to it. It’s the seven-decade long heritage of creating the finest and most captivating fragrances that we believe our customers deserve to explore. Being the beauty destination of India, we understand our customers and believe that every product that we offer in-store & online, is a reflection of our vision and philosophy.”

City Today News

(citytoday.media)

9341997936

CPRI Celebrates Diamond Jubilee

CPRI Celebrates Diamond Jubilee Central

Power Research Institute, an autonomous body under Ministry of Power, Government of India located at Sadashivanagar, Bangalore is celebrating Diamond Jubilee with the Institute Day Celebration

on 16h January 2020 on completion of its 60 years services in Indian Power Sector. The Chief Guest for the event is Prof, G.D. Yadav, Padma Shri and Professor Emeritus from Institute of Chemical Technology, Mumbai who will be delivering the Jawaharlal Nehru Memorial lecture on the topic, “The Global Energy Scenario and Hydrogen Economy”. During the event, CPRI-Diamond Jubilee Special Postal Cover will be released by Dr. Charles Lobo, IPOS, Chief Postmaster General, Karnataka Circle.

CPRI, which was initially established in Bangalore and Bhopal in 1960 is now spread across other locations like Hyderabad, Nagpur, Noida, Kolkata and Guwahati. It is headed by Shri. V.S. Nandakumar as Director General. The Institute has established a brand name as an international accredited testing organization on par with other reputed international test houses. It is one of the 12 laboratories in the world approved for Short Circuit testing and certification of power equipment. Manufacturers from all over the world find it as a preferable destination for their electrical testing needs conforming International standards. CPRI is recognized for certifying electrical equipment for energy efficient operation in accordance with the standards & labelling programme of Bureau of Energy Efficiency.

CPRI is the forerunner in undertaking R&D activities, as well as the nodal agency of Ministry of Power, Government of India for funding Research Schemes, in the areas of Generation, Transmission and Distribution of electricity. Progressive developments are happening in projects on Innovative technologies like Superconducting cables, LED devices, light weight polymer insulators and components, Electricity based Clean Cooking, Smart Meters, Waste to energy, Energy Storage and Renewable energy. MoUs have been entered with IITS and other research organizations in India for collaborative development and demonstration of technologies.

The Institute has significantly contributed to the Government of India programmes like, “Restructured Accelerated Power Development & Reforms Programme (R-APDRP) and the prestigious “Rajiv Gandhi Grameen Vidyuthikaran Yojana” (RGGVY). The Institute is regularly offering Consultancy services, Third party inspection and Training Programmes for electrical utilities and manufacturers in India and abroad.

City Today News

(citytodaymedia)

9341997936

Ranitidine not banned; a trusted, safe & effective drug for years

Bengaluru; January 16, 2020: A group of prominent city doctors from different specialties met the media today for a discussion to separate facts from myths about Ranitidine, an active pharmaceutical ingredient (API) used in certain antacids. During the meet, the doctors said that there is lot of misconception and unnecessary confusion on ranitidine.

A popular, ages-old medicine used to treat gastric acidity, Ranitidine was commercially introduced in 1981 and has stood up to the expectations of medical fraternity for being safe and efficacious. Ranitidine features on the World Health Organization’s List of Essential Medicines.

Contrary to the popular perception created, Ranitidine has not been banned. None of the key pharmaceutical regulators such as the US FDA, the Drug Controller General of India (DCGI) /CDSCO have asked for a ban. However, the recall by a few manufacturers in India was purely voluntary. The US FDA tested numerous ranitidine products and found levels of NDMA similar to levels one would be exposed to if they ate common foods like grilled or smoked meats.

The US FDA in its recent statement issued on January 8, 2020 has said that NDMA is a known environmental contaminant found in water and certain foods. A person taking a drug that contains NDMA at-or-below the acceptable daily intake limit every day for 70 years is not expected to have an increased risk of cancer.2
Reiterating US FDA’s stand on the issue, Dr. T. R. Raghu, HOD-Cardiology, Sri Jayadeva Institute of Cardiovascular Sciences and Research said, “The USFDA, in its statement, has confirmed that ranitidine does not lead to cancer in typical stomach conditions of humans. Cardiologists like me have been prescribing ranitidine for several years, and haven’t yet come across any adverse reactions in our patients. Ranitidine is an age-old molecule commonly prescribed by cardiologists with other drugs for heart. It is a safe and efficacious drug for hyperacidity. In fact, ranitidine is better because it does not cause drug interaction with Clopidogrel and Aspirin (which cardiologists prescribe often) unlike other class of antacids.”

Echoing similar opinion, Dr Ashok Kumar, Professor and HOD, Cardiothoracic and Vascular Surgery, Sri Jayadeva Institute of Cardiovascular Sciences and Research said, “The CDCSO/DCGI never banned ranitidine. They have only asked the state bodies to get the product tested from manufacturers. Blood thinning agents are given to cardiac patients which causes hyperacidity. In order to counter this acidity, ranitidine is prescribed in combination, and we have always found it safe for our patients over so many years. Ranitidine is given to outdoor patients as well as to those patients in ICU when they are dealing with stress ulcers.”
Dr Nagendra Kumar, Consultant Pediatric Gastroenterologist, Hepatology and Nutrition, Indira Gandhi Institute of Child Health, Columbia Asia Hospitals said, “We have gathered here to dispel the misinformation around ranitidine. It is an age old molecule, low priced and affordable medication. I have been prescribing my patients for ranitidine for years and none of my patients have reported any serious adverse effect of the medicine consumption. There is no co-relation between ranitidine and cancer seen in my practice of so many years.”
Dr Purushottam Chavan, Assistant Professor, Head and Neck Onco-Surgeon, Kidwai Memorial Institute of Oncology said, “US FDA has clearly stated that a person taking a drug that has NDMA below the acceptable limit every day for 70 years is not expected to have an increased risk of cancer. Also, ranitidine is usually prescribed for short duration. As per the latest update from US FDA, the acceptable daily intake limit for NDMA is 0.096 micrograms (96 nanograms) or 0.32 ppm for ranitidine containing products.”
Dr Arun KN, Nephrologist, Bhagwan Mahaveer Jain Hospital said, “Ranitidine came to India in 1980s when I was a medical student. Surgeries for peptic ulcers, which were one of the commonest surgeries in those times, have become very rare within a decade after ranitidine came. At present, there is a lot of confusion among patients, media and healthcare practitioners about ranitidine and its side effects. The USFDA has certified that ranitidine is safe for human consumption. NDMA is a naturally occurring contaminant which is present in air, food, water etc. As a senior nephrologist, I want to assure patients that ranitidine is a safe and reliable drug. Recently, the Brihanmumbai Municipal Corporation (BMC) asked Ranitidine to be made available again in all civic hospitals and dispensaries for use after seeing the test reports on Ranitidine from the laboratory which showed no contamination in the drug. The test reports prove that the drug is safe for consumption.”

City Today News

(citytoday.media)

9341997936